You can buy or sell GSK and other stocks, options, and ETFs commission-free!
GlaxoSmithKline plc, also called GlaxoSmithKline, is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals; Pharmaceuticals R&D; Vaccines and Consumer Healthcare.
Emma N. Walmsley
Middlesex, Greater London
52 Week High
52 Week Low
Glaxo-Backed Lyell Immunopharma Wobbles in Trading Debut
(Bloomberg) -- Lyell Immunopharma Inc., a cancer drug developer backed by GlaxoSmithKline Plc and Celgene Corp., seesawed in its trading debut after raising $42
iTeos Therapeutics Shares Rise 32% on Deal With GlaxoSmithKline
By Chris Wack iTeos Therapeutics Inc. shares rose 32% to $26.54 after the company said it and GlaxoSmithKline Plc agreed to develop and commercialize EOS-448,
— per share
Available Jul 28
iTeos stock jumps 60% after company announces deal with GSK
Shares of iTeos Therapeutics Inc. ITOS, +0.86% soared 58.5% in premarket trading on Monday after the company announced a deal with GlaxoSmithKline GSK, -0.20% t